SMARCA2 and lung adenocarcinoma: As mutations in Trp53 are commonly found in murine lung adenocarcinomas, we investigated whether there was a change in the observed Trp53 mutation rate in these lung adenocarcinomas as a function of Brm or Brg1 loss.